<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Based on the clinical analysis and the microorganism characteristics, OC treatment consists of the elimination of the identified predisposition factors through buccal and prosthesis hygiene as well as the use of topical or systemic antifungal agents [
 <xref rid="B13-pharmaceutics-10-00257" ref-type="bibr" class="xref">13</xref>,
 <xref rid="B14-pharmaceutics-10-00257" ref-type="bibr" class="xref">14</xref>]. The regular teeth, buccal cavity, and denture cleaning with antiseptic rinses containing chlorhexidine or hexetidine is an effective approach to reduce 
 <italic class="italic">Candida</italic> spp. load in the oral cavity [
 <xref rid="B5-pharmaceutics-10-00257" ref-type="bibr" class="xref">5</xref>,
 <xref rid="B8-pharmaceutics-10-00257" ref-type="bibr" class="xref">8</xref>]. However, the use of topical or systemic antifungal agents such as nystatin, miconazole, clotrimazole, fluconaloze, itraconazole, echinocandins, flucystein, and amphotericin B represent other important treatment strategies for OC, especially when the patientâ€™s immunity is a relevant aspect to be considered [
 <xref rid="B5-pharmaceutics-10-00257" ref-type="bibr" class="xref">5</xref>,
 <xref rid="B6-pharmaceutics-10-00257" ref-type="bibr" class="xref">6</xref>,
 <xref rid="B12-pharmaceutics-10-00257" ref-type="bibr" class="xref">12</xref>].
</p>
